Cygnus Technologies, LLC Email Format

Biotechnology ResearchNorth Carolina, United States51-200 Employees

Cygnus Technologies, LLC, part of Maravai LifeSciences, provides analytical tools and services to detect host cell proteins and other process-related impurities, supporting the safety evaluation of biotherapeutics before human trials, regulatory submission, and commercial release. Founded by Ken Hoffman in 1997 and based in Leland, North Carolina, the company relies on proprietary approaches to enable robust impurity analysis in biopharmaceutical development and manufacturing. It maintains ISO 9001:2015 certified quality management systems, underscoring its emphasis on quality and consistency.

Its customer base comprises biopharmaceutical developers working on therapeutic proteins, vaccines, antibodies, plasma derivatives, and gene therapies who rely on ready-made assays and custom services to quantify host cell proteins and other impurities. In 2024, the company launched the C1 HCP ELISA Assay, reflecting ongoing product development to support quality assurance in biomanufacturing.

Sign up for free to view info

Company overview Employee directory